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Background Reticulate pigmentary disorders include the rare autosomal dominant
Galli–Galli disease (GGD) and Dowling–Degos disease (DDD). Clinical diagnosis
between some of the subtypes can be difficult due to a degree of overlap
between clinical features, therefore analysis at the molecular level may be neces-
sary to confirm the diagnosis.
Objectives To identify the underlying genetic defect in a 48-year-old Asian-Ameri-
can woman with a clinical diagnosis of GGD.
Methods Histological analysis was performed on a skin biopsy using haematoxy-
lin–eosin staining. KRT5 (the gene encoding keratin 5) was amplified from geno-
mic DNA and directly sequenced.
Results The patient had a history of pruritus and hyperpigmented erythematous
macules and thin papules along the flexor surfaces of her arms, her upper back
and neck, axillae and inframammary areas. Hypopigmented macules were seen
among the hyperpigmentation. A heterozygous 1-bp insertion mutation in KRT5
(c.38dupG; p.Ser14GlnfsTer3) was identified in the proband. This mutation
occurs within the head domain of the keratin 5 protein leading to a frameshift
and premature stop codon.
Conclusions From the histological findings and mutation analysis the individual was
identified as having GGD due to haploinsufficiency of keratin 5.
What’s already known about this topic?
• Mutations in keratin 5 have been identified as an underlying cause of Galli–Galli
disease (GGD).
What does this study add?
• Identification of a previously unreported frameshift mutation in keratin 5 resulting
in a premature stop codon provides further evidence that GGD is caused by haplo-
insufficiency of keratin 5.
Galli–Galli disease (GGD) is a rare autosomal dominant con-
dition in the class of reticulate pigmentation disorders. It is
an allelic variant of the clinically similar disorder, Dowling–
Degos (DDD, OMIM 179850), but with the reported distin-
guishing histological feature of acantholysis. However, the
number of cases described is small and acantholysis has also
been observed in cases with DDD.1 Patients classically pres-
ent with pigmented lesions involving large body folds and
flexural areas. In rare cases, the face can be involved and
comedonal-like papules and pitted scarring can be seen. GGD
was first described in 1982 when two brothers were
reported to have a histologically distinct disease, which
included acantholysis.2 Since then a number of cases of both
DDD and GGD have been reported in the literature associ-
ated with mutations in keratin 5 (encoded by the KRT5
gene).1,3–8 Herein, we report the case of an Asian-American
woman with a clinical diagnosis of GGD and a previously
unreported mutation within KRT5.
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Materials and methods
A 4-mm punch biopsy was taken from the right axilla for his-
tological analysis by haematoxylin–eosin (H&E) staining.
Genomic DNA was obtained with informed consent and
appropriate ethical approval that complies with the Declaration
of Helsinki principles. All exons and intron/exon boundaries
of KRT5 were amplified using primers specific to KRT5 and
polymerase chain reaction products were directly sequenced
(Data S1; see Supporting Information).
Results
Clinical features
A 48-year-old Asian-American woman presented with a 20-
year history of pruritus and an ever-present rash. Initially the
rash was present on the flexural surface of her arms, and grad-
ually spread to involve her neck, axillae and breast folds. The
pruritus characteristics were made worse on extreme heat and
perspiration. There were no relieving factors reported and no
history of pain or photosensitivity. Physical examination
revealed hyperpigmented and erythematous macules and thin
scaly papules coalescing into plaques along the flexor surfaces
of her arms, her upper back and neck, axillae and inframam-
mary areas (Fig. 1). Amidst the hyperpigmentation were scat-
tered hypopigmented macules. She also had a discrete area of
hypopigmentation on her abdomen. Comedonal-like papules
were present on her chin and perioral area while there were
focal areas of pitted scarring on her cheeks. She was initially
prescribed hydrocortisone cream 25% twice daily and treti-
noin cream 0025% once nightly. The tretinoin cream was
subsequently stopped because of skin irritation. Subsequently
she has used hydrocortisone cream twice weekly and daily
emollients as needed.
Histology and mutation analysis
Histological analysis of a biopsy showed lentiginous epidermal
hyperplasia with elongated rete ridges and suprapapillary plate
thinning, focal orthokeratosis, small milia-like cysts and kera-
tin plugs, and suprabasilar acantholysis (Fig. 2a,b).
A heterozygous 1-bp insertion mutation in exon 1 of KRT5
(c.38dupG; Ser14GlnfsTer3) was identified in the proband
leading to a frameshift and premature stop codon two amino
acids downstream (Fig. 2c,d). The mutation occurred within
the head domain of the keratin 5 polypeptide and is predicted
to lead to haploinsufficiency of keratin 5. The mutation was
excluded from two unaffected family members (her 28-year-
old daughter and 16-year-old son) and 90 control DNA sam-
ples from unrelated white subjects using fluorescent DNA
fragment analysis. This variant is not present on the Exome
Variant Server [NHLBI GO Exome Sequencing Project (ESP),
Seattle, WA, U.S.A.; http://evs.gs.washington.edu/EVS/] nor
on the dbSNP database.
Discussion
Mutations in the KRT5 gene have been reported since the early
1990s as the cause of epidermolysis bullosa simplex (EBS).9
Keratin 5, a type II keratin protein, partners with the type I
keratin 14 and this keratin pair is predominantly expressed
within the basal cells of the epidermis where blistering in EBS
occurs. There is some genotype–phenotype correlation
between the dominant-negative mutations in KRT5 that cause
EBS; the severe Dowling–Meara form is normally due to muta-
tions in the highly conserved helix boundary domains at
either end of the rod domain, while mutations throughout the
rod domain tend to result in milder forms of EBS. The subtype
of EBS associated with mottled pigmentation (EBS-MP) is most
often due to a specific mutation, p.Pro25Leu, in the head
(a) (b)
(c) (d)Fig 1. Clinical features of Galli–Galli disease.
Hyperpigmented slightly scaly papules
coalescing in a reticulate fashion over flexural
areas, including (a) the anterior neck and (b)
axillae; (c) reddish-brown thin papules (5–
9 mm) in the inframammary area with
multiple 4–7-mm hypopigmented macules
scattered on the abdomen; (d)
hypopigmented Galli–Galli disease macules on
the forearm.
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domain of keratin 5.9–11 The KRT5 mutations reported in GGD
and DDD are also within the head domain but are nonsense
or frameshift mutations resulting in premature termination co-
dons; these lead to haploinsufficiency of keratin 5 rather than
a dominant-negative defect.1
The hyperpigmentation observed in disorders such as EBS-
MP, GGD or DDD that is associated with mutations in KRT5,
has led to a growing body of evidence that keratin 5 may also
play a role in the function or transportation of melanosomes.
How melanosomes are transferred from melanocytes to kerati-
nocytes is still unclear although a number of mechanisms have
been proposed.12 How keratin 5 might be involved in this
process remains unknown.
Although many cases of the main reticulate pigmentary dis-
orders can be characterized by their clinical and histopathologi-
cal features, there is a certain degree of overlap between the
subtypes of reticulate pigmentary disorders, for example
between DDD and the acantholytic variant GGD, making diag-
nosis difficult.13 Analysis at the molecular level is useful to con-
firm the subtype and identify allelic variants.13 GGD is due to
mutations in KRT5; DDD is caused by mutations in KRT5 or
KRT14 (http://www.interfil.org),9 and most recently it has
been shown some cases are due to mutations in POFUT1 (which
encodes protein O-fucosyltransferase 1).14 Reticulate acropig-
mentation of Dohi is associated with mutations in ADAR1 (aden-
osine deaminase, RNA-specific 1) on chromosome 1, and
mutations in ADAM10, encoding a zinc metalloprotease, have
recently been identified in several kindreds with reticulate acro-
pigmentation of Kitamura;15 at present there are no genes/gene
loci associated with Haber syndrome.13 As already reported,
with the advent of whole-exome sequencing at least two new
genes associated with reticulate pigmentary disorders have been
identified, POFUT1 and ADAM10, and further genes may still be
identified in cases with reticulate pigmentation with no muta-
tion to date in a known gene.
This work expands the spectrum of known mutations in
KRT5 and strengthens the body of evidence that GGD is caused
by haploinsufficiency of keratin 5.
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leading to a premature stop codon,
Ser14GlnfsTer3. K5, keratin 5.
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